Disclosure
-
Celltrion Healthcare UK Ltd are committed to acting with openness and transparency across all our interactions with healthcare professionals (HCPs), other relevant decision makers (ORDMs) healthcare organisations (HCOs) patient organizations (POs) and members of the public to support patient care.
Our interactions are guided by transparency to ensure trust and confidence in the Pharmaceutical Industry and we support disclosure of these relationships to demonstrate their integrity. Cellltrion Healthcare UK Ltd are committed to working within the Association of the British Pharmaceutical Industry’s (ABPI) Code of Practice. To support this, our transparency disclosure of payments to UK HCPs; ORDMs: HCOs; POs and members of the public are published below.
Health Professionals, Other Relevant Decision Makers and Healthcare Organisations:
For transparency reports for HCPs, ORDMs and HCOs, see the Disclosure UK database hosted on the website of the ABPI, visit www.disclosureuk.org.uk.
Patient Organisations, Members of the Public and journalists:
Up until 2023 there has been no payment to patient organisations, members of public including patients and journalist.
2023 - Information on payments made to support the work of patient organisations, Members of the Public (including patients and journalists). – please use this [link]
2024 - Information on payments made to support the work of patient organisations, members of public, including patients and journalists. – please use this [link]
For information on our methodological approach please see below.
Methodological approach
Year Download 2021 Download ↓ 2022 Download ↓ 2023 Download ↓ 2024 Download ↓
